Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune...

Data demonstrates that STC-15, an oral METTL3 inhibitor, exhibits efficacy as a single agent and in combination with venetoclax using patient-derived tumor models STC-15 Phase 1 study in solid...

Debuting at TCEA 2023, New PowerLite and BrightLink Models Enhance Collaboration for Education and Corporate Environments LOS ALAMITOS, Calif., Jan. 25, 2023 /PRNewswire/ -- With connected...

NAFA Fleet Management Association (NAFA), the vehicle fleet industry's largest membership association, today unveiled its education session line-up for NAFA 2023 Institute & Expo, the industry's...

Lumentum Holdings Inc. ("Lumentum") today announced that management will host the "LITE 2023: Lumentum Investor Technology Event", during the 2023 Optical Fiber Communication Conference and...